drugset / Trial / NCT00373113
A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine
RandomizedParallel-groupOpen-labelTreatment
Summary
To compare efficacy and safety of Sunitinib and Capecitabine in subjects with advanced breast cancer who failed both a taxane and an anthracycline chemotherapy regimen or failed with a taxane and for whom further anthracycline therapy is not indicated
Timeline
- Start
- 2006-11
- Primary completion
- 2009-10
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Capecitabine | Small molecule | 1250 mg/m2 | — |
| Subject | Sunitinib | Small molecule | 37.5 mg | — |